The HP D300e BioPrinter “Prints” Pharmaceutical Samples Instead of Ink

HP Inc. is the world leader in fluidic based micro Electro-Mechanical Systems (MEMS) devices embodied in inkjet printing today.

HP has invested many billions of dollars in research and development, as well as capital equipment over the past three decades to create the world’s largest digital printing company.

All this provides the foundation to extend this technology into new domains. HP’s Specialty Printing Systems (SPS) and the Microfluidics Technology and Operations (MTO) teams have collaborated to bring HP’s first life science application in this space to market: The HP D300e BioPrinter with inkjet printing technology is enabling automated laboratory dispensing to “print” pharmaceutical samples instead of ink.

The BioPrinter is being used by labs and pharmaceutical companies all over the world, including the Centers for Disease Control & Prevention (CDC) in the Antibiotic Resistance (AR) Lab Network, to perform antimicrobial susceptibility testing for health departments and hospitals nationwide.

*NEW* On July 13, 2020 HP announced an update to their COVID-19 response efforts, the donation of BioPrinters to research institutions across the U.S. and EMEA to accelerate drug and vaccine research to combat the pandemic.

Click here to learn more!


ImageNet Consulting of the Treasure Coast Now Providing New Thermal Camera Technology